| Literature DB >> 15162157 |
D Gisselsson1, L Gorunova, M Höglund, N Mandahl, P Elfving.
Abstract
Most renal cell carcinomas (RCC) show only simple chromosomal changes. However, a more complex cytogenetic pattern has been found in a subgroup of aggressive RCC, indicating that further accumulation of chromosome changes could play a role in tumour progression. To explore the possible mechanisms behind cytogenetic evolution in RCC, a parallel assessment of chromosome mutations and mitotic segregation pattern in eight tumours was performed. In the majority of cases, no abnormalities in the cell division machinery were found and the rate of alterations in chromosome copy number, as measured by interphase FISH, was similar to that in non-neoplastic cells. This was reflected by relatively simple karyotypes, with little cytogenetic intratumour heterogeneity. In contrast, another group of tumours exhibited several cytogenetically related clones with additional structural chromosomal changes at two or more ploidy levels and a frequency of copy number alterations that was higher than in normal cells. In these cases, the telomere repeat sequences were abnormally short and chromosomal breakage-fusion-bridge events were observed at cell division, as well as multipolar configurations and supernumerary centrosomes. Abnormalities of the cell division machinery may thus contribute to the evolution of complex karyotypes and genetic intratumour heterogeneity in a subgroup of RCC.Entities:
Mesh:
Year: 2004 PMID: 15162157 PMCID: PMC2409829 DOI: 10.1038/sj.bjc.6601803
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640
Clinical data and karyotypes
| 1 | 51/F | Clear cell | I | pT2 | 45,XX,del(3)(p12),der(13;14)(q10;q10) [15] |
| 2 | 64/F | Clear cell | I | pT2 | 45,XX,−3,der(7)t(3;7)(q11;q11),der(19)t(7;19)(q11;q13) [21]/46,XX [22] |
| 3 | 82/F | Clear cell | I | pT1 | 42,XX,der(2)t(2;3)(p25;q11),−3,−4,+5,del(11)(p13),−14,der(17)t(17;18)(p11;q11),−18,−19 [5]/46,XX [9] |
| 4 | 58/F | Clear cell | II | pT3c | 47,XX,+3 [cp3]/47–48,X,−X,+3,+17,+r [cp3]/47–49,XX,+17 [2]/47,XX,+7 [cp5]/47,XX,+18 [cp3]/48,XX,+X [cp2]/46,XX [25] |
| 5 | 79/M | Clear cell | II | pT2N1 | 47–48,X,−Y,+5,+8,+12,+16,+der(?17)del(17)(p13)del(17)(q23),−18,−20 [cp12] |
| 6 | 70/M | Clear cell | II | pT1 | 43,X,−Y,t(1;17)(p36;q21),der(1)t(1;17)(p36;q21),+5,der(?7)t(3;7)(q21;p22),−14,−15,der(15)t(5;15)(q11;p11), dic(16;?)(p13;?),−18 [cp28]/42–43,idem,add(14)(q32),−der(15)t(5;15),+15[cp4]/43,idem,add(14)(q32) [2]/43, idem,dic(14;?)(q32;?)[cp6]/43–44,idem,+r [cp3]/80–86,idemx2 [cp7]/84–86,idemx2,dic(14;?)x2 [cp3] |
| 7 | 66/M | Clear cell | II | pT3a | 44–46,X,−Y,der(1)t(1;1)(p35;q12),+3,der(3)del(3)(p12p21)del(3)(p25)x2,−6,+7,add(11)(q21),−14,−19,−22,+r, +mar [cp20]/43,X,−Y,del(1)(p34),der(3)del(3)del(3),+7,−9,add(11),−14 [cp4]/44,X,−Y,der(3)del(3)del(3),−6,+7, i(8)(q10),t(10;19)(q22;q13),−14 [cp4]/68–71,XX,−Y,+3,der(3)del(3)del(3)x2,−6,+7,+7,−8,+12,−13,−14,der(14) |
| t(4;14)(q12;p11),der(14)t(8;14)(q11;p11),+16,−18,+20,+21,+22 [cp18]/83–91,idemx2 [cp13] | |||||
| 8A | 39/M | Papillary | II | pT3a | 48–49,X,−Y,+7,+7,+12,+17 [25] |
| 8B | 48–49,X,−Y,+7,+7,+12,+17 [cp59]/49,idem,der(19)t(3;19)(q13;q13) [cp25]/48,idem,−8,der(15)t(8;15)(q11;p11), der(19)t(3;19) [cp3]/97–98,idemx2,add(19)(q13)x2 [cp3]/46,XY |
F=female; M=male.
Figure 1Representative karyotype of case 7, showing several structural changes (arrows) and ring chromosomes (arrowhead; A); clonal evolution of structural changes in tumour 8B illustrated by the stem line karyotype (top), identical to that of tumour 8A, the partial karyotypes of the diploid side lines with der(15)t(8;15) (right) and der(19)t(3;19) (left), and the hypertetraploid side line with add(19) (bottom; B).
Figure 2Interphase cell from case 6, showing multiple centromeric signals for chromosome 17 (A); normal telomeric signal pattern in case 8A (B), compared to 8B (C), showing TTAGGG-negative chromosome ends (arrows); multiple chromosome ends and a ring chromosome (arrow) without TTAGGG signals in case 7 (D); telomeric fusions (E), an anaphase bridge (F) and a tripolar cell division coordinated by three centrosomes (orange, G) in case 6; multiple centrosomes in a binucleated interphase cell in case 7 (H).
Percentage of cells with chromosome copy numbers deviating from the modal value
| 1 | 5 (2) | 5 (2) | 4 (2) | 6 (2) | 5 (2) | 5 |
| 4 | 6 (2) | 12 (2) | 12 (2) | 13 (2) | 5 (2) | 12 |
| 5 | 15 (2) | 8 (2) | 16 (3) | 6 (2) | 8 (2) | 8 |
| 6 | 21 (2) | 23 (2) | 26 (2) | 22 (2) | 19 (2) | 22 |
| 7 | 39 (2) | 47 (2) | 31 (2) | 23 (2) | 19 (2) | 31 |
| 8A | 2 (2) | 26 (4) | 2 (2) | 1 (2) | 8 (3) | 2 |
| Fibroblasts | 8 (2) | 12 (2) | 10 (2) | 10 (2) | 6 (2) | 10 |
| Lymphocytes | 1 (2) | 5 (2) | 1 (2) | 2 (2) | 2 (2) | 2 |
Modal copy numbes are within parentheses;
centromeric alpha-satellite probe.
Ploidy levels and cell division abnormalities
| 1 | 2n | 1 | 0–2 | 0 | 0 | 0 |
| 2 | 2n | 1 | 0–1 | 0 | 1.8% | 0 |
| 3 | 2n | 1 | 0–1 | 0 | 0 | 0 |
| 4 | 2n | 6 | 0–1 | 10% | 0 | 0 |
| 5 | 2n | 1 | 0–1 | 0 | 0 | 0 |
| 6 | 2n | |||||
| 4n | 7 | 0–1, 7–8 | 33% | 24% | 3.9% | |
| 7 | 2n | |||||
| 3n | ||||||
| 4n | 5 | 1, 5–20 | 46% | 20% | 3.2% | |
| 8A | 2n | 1 | 0–1 | 0 | 0 | 0 |
| 8B | 2n | 4 | 0–2, 3–7 | 38% | 13% | 1.9% |
| 4n |
Measured in cells of the lowest ploidy level.
Proportion of cells with dicentric chromosomes, telomeric fusions, or ring chromosomes.
Clones distinguished mainly by copy-number variability.
Multiple centrosomes detected by immunofluorescence.